LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
© LexDana · beta
LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
LexDanaLexDanabeta

Insights

Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.

AllCopyright & Trade Secrets59Federal Circuit877ITC / Section 33788Patent Litigation216Patent Prosecution126Pharma & ANDA62PTAB686Supreme Court61Trademark158USPTO Policy78Unsorted257

Tagged ptab procedure · clear

PTAB

University Successfully Argues Prior Art S Disclosures Were Not by Another

LSI CORPORATION v. REGENTS OF THE UNIVERSITY OF MINNESOTA Before Dyk, Reyna, and Hughes. Appeal from the Patent Trial and Appeal Board. Summary: Determining whether a patent or application’s disclosure is “by another” under § 102(e)…

August 15, 2022·PTAB·2 min read
PTAB

Federal Circuit Has Jurisdiction to Review Joinder Decisions in IPRs

FACEBOOK, INC., V. WINDY CITY INNOVATIONS LLC Before Prost, Plager, and O’Malley. Appeal from the Patent Trial and Appeal Board. Summary : The Federal Circuit has jurisdiction to review challenges to the Board's joinder decision in an instituted…

September 8, 2020·PTAB·2 min read
PTAB

Same-Party and New-Issue Joinder Impermissible in IPRs

FACEBOOK, INC., V. WINDY CITY INNOVATIONS LLC Before Prost, Plager, and O’Malley. Appeal from the Patent Trial and Appeal Board. Summary: An IPR petitioner may not join itself to an earlier IPR in which it was already a party, and may not add new…

March 19, 2020·PTAB·1 min read
Data: FDA Orange & Purple Books · prosecution & litigation metadata · read-only.